Key Laboratory of Smart Drug Delivery, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China.
The Institutes of Integrative Medicine of Fudan University, Shanghai, China.
Cancer Biother Radiopharm. 2023 Oct;38(8):521-527. doi: 10.1089/cbr.2020.3805. Epub 2020 Sep 22.
This study investigated irinotecan loading efficiency and release profiles of CalliSpheres . CalliSpheres with size of 50-150, 100-300, and 300-500 μm and irinotecan at different amounts (20, 40, 80, and 100 mg) and concentrations (5 and 10 mg/mL) were prepared for experiments. Dynamic light scattering and Agilent 1260 high-performance liquid chromatography system were used to quantify bead diameters and the efficiency of irinotecan loading and releasing properties, respectively. The diameters of CalliSpheres with all sizes were reduced after being loaded with irinotecan compared with unloaded ones with shrinkage rate ranging from 8.5% to 16.2%. Above 80% irinotecan was incorporated with CalliSpheres with all sizes when being loaded with irinotecan 20, 40, and 80 mg, while loading efficiencies were 70%-80% when being loaded with irinotecan 100 mg. Besides, elevated loading efficiency was observed at a higher concentration of irinotecan solutions (10 mg/mL) compared with a lower concentration (5 mg/mL) for CalliSpheres with all sizes. As to release profiles, irinotecan was released from CalliSpheres very quickly, and irinotecan release rate was elevated in CalliSpheres with smaller size than CalliSpheres with larger size within the first 12 h, whereas it was similar among CalliSpheres with different sizes at 24 and 48 h with maximum release rate ∼100%. In addition, fetal bovine serum seemed to have an effect on the accelerating irinotecan release. CalliSpheres exhibits good physical characteristics, satisfied irinotecan loading efficiency, and acceptable releasing profiles.
本研究考察了伊立替康在 CalliSpheres 中的载药效率和释放特性。制备了粒径分别为 50-150μm、100-300μm 和 300-500μm 的 CalliSpheres 以及不同载药量(20、40、80 和 100mg)和浓度(5 和 10mg/mL)的伊立替康。采用动态光散射和安捷伦 1260 高效液相色谱系统分别对载药前后的载药微球粒径和载药效率进行定量分析,考察伊立替康的释放性能。与未载药的微球相比,所有粒径的 CalliSpheres 在载药后粒径均减小,收缩率为 8.5%-16.2%。当载药 20、40 和 80mg 时,所有粒径的 CalliSpheres 均能包裹 80%以上的伊立替康,而当载药 100mg 时,载药效率为 70%-80%。此外,所有粒径的 CalliSpheres 在较高浓度(10mg/mL)的伊立替康溶液中表现出更高的载药效率,而在较低浓度(5mg/mL)时则较低。就释放特性而言,伊立替康从 CalliSpheres 中迅速释放,在最初的 12h 内,粒径较小的 CalliSpheres 中的伊立替康释放速度高于粒径较大的 CalliSpheres,而在 24 和 48h 时,不同粒径的 CalliSpheres 之间的释放速度相似,最大释放率约为 100%。此外,胎牛血清似乎对加速伊立替康释放有影响。CalliSpheres 具有良好的物理特性、令人满意的载药效率和可接受的释放特性。